Strand Therapeutics

Strand Therapeutics

  • Founded: 2018
  • Location: Boston, MA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: Undisclosed
  • Product link:
  • Funding: $45M A Nov 2022; $52M A Jun 2021; $6M seed Jun 2019
  • Investors: FPV, Eli Lilly and Company, Potentum Partners, Playground Global

job board

Short description:

Gene Therapy

Drug notes:

Undisclosed RD hematological cancers

Long description:

Strand Therapeutics is developing mRNA therapeutics to treat cancer, heart diseases and rare diseases. mRNA has recently emerged as an effective, multi-functional and potentially curative treatment option for many patients. Strand’s approach to mRNA therapeutics is unique - creating mRNA constructs that contain information for self-replication and genetically programmed logic circuits. This application of synthetic biology to RNA therapeutics enables the creation of programmable, long-acting mRNA drugs such that the location, timing and intensity of expression can all be controlled. Stand has initially focused on treatment options for solid tumor cancers.


Strand Therapeutics
Co-op, Nanoparticle Process Development
Boston, MA|6 days ago
Strand Therapeutics
Co-op, Automation
Boston, MA|10 days ago
Strand Therapeutics
Co-op, Bioanalytical
Boston, MA|10 days ago
Strand Therapeutics
Senior System Administrator
Boston, MA|16 days ago
Strand Therapeutics
Intern, Computational Biology
Boston, MA|27 days ago
Strand Therapeutics
Intern, Data Analytics and Machine Learning
Boston, MA|27 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy